Roivant Sciences Ltd. (ROIV) Presents at Leerink Global Healthcare Conference 2026 Transcript
Summarize this article with:
SA Transcripts158.92K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Roivant Sciences Ltd. (ROIV) Leerink Global Healthcare Conference 2026 March 11, 2026 8:40 AM EDT Company Participants Matthew Gline - CEO & Director Conference Call Participants David Risinger - Leerink Partners LLC, Research Division Presentation David RisingerLeerink Partners LLC, Research Division Hi, everybody. So my name is Dave Risinger. On behalf of Leerink Partners. I just wanted to thank you for joining our conference. It's very much my pleasure to introduce Matt Gline, the CEO of Roivant. He's just putting a little sugar in his coffee and then we'll get started. But really appreciate you being here and his team members Richard and Keyur are in the audience as well. So I thought it would be great for you to just maybe kick off, Matt, with some opening comments on the business prospects. You've had a tremendous run of good news and hoping for good -- for more good news ahead, but I would love you to start with some opening comments. Matthew GlineCEO & Director Yes. Thanks, Dave. Thanks for having us. It's obviously it's a great venue for a conference. I think the best in Miami at present. So thanks, Dave. Thanks for having us. Look, it's been -- I don't know it's hard looking out over the room to know exactly who's got what level of familiarity, but it's been a really transformative period for us. And I think in some ways, we've been built for a long time to find drugs that matter, develop them in creative ways. I think we've done a phenomenal job in indication selection and sort of building a pipeline. And at this point, I feel like the fruits of that labor have like finally come together. And so as many of you may know, mid last year, we got data